Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 271.27 | (100.70) | (144.75)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 347.30 | (53.40) | (75.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Vanda Pharmaceuticals surges as FDA approves mot... | 31-Dec-2025 | ShareCast |
| AstraZeneca is sued over asthma drug deal | 27-May-2009 | LA Times |
| Local Digest | 09-May-2009 | Washington Post |
| Local Digest | 08-May-2009 | Washington Post |
| Currency | US Dollars |
| Share Price | $ 7.33 |
| Closing Price Change | $ -0.01 |
| % Change | 0.00 % |
| 52 Week High | $0.00 |
| 52 Week Low | $0.00 |
| Volume | 0 |
| Shares Issued | 52.38m |
| RiskGrade | 297 |
| Strong Buy | 0 |
| Buy | 3 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 4 |

You are here: research